Birth control Press Release

Title Picture
12/08/2018 - 01:30
Novartis data demonstrates consistent efficacy and tolerability of Kisqali combination therapy in HR+/HER2- advanced breast cancer in patients with difficult-to-treat visceral disease
Novartis's picture
Novartis
12/03/2018 - 02:47
7-INCHES FOR PLANNED PARENTHOOD
Planned Parenthood's picture
Planned Parenthood
12/01/2018 - 01:20
Novartis announces longer-term analyses from pivotal Kymriah trials that showed durable responses are maintained in patients with advanced blood cancers
Novartis's picture
Novartis
11/29/2018 - 18:02
Planned Parenthood Launches New Initiative This is Health Care With Issa Rae, Chelsea Handler, and Other Artists to Reaffirm Reproductive Health Care as Standard Medical Care
Planned Parenthood's picture
Planned Parenthood
11/27/2018 - 22:37
First Trial Launches to Test Effectiveness of Male Contraceptive Gel
Population Council's picture
Population Council
11/16/2018 - 14:37
Novartis receives positive CHMP opinion to expand Kisqali combination therapy to all women with HR+/HER2- locally advanced or metastatic breast cancer
Novartis's picture
Novartis
11/14/2018 - 08:00
Running to stand still? Meeting family planning targets.
Population Matters's picture
Population Matters
11/13/2018 - 20:56
Population Council to Determine Feasibility of Fast-Tracking Oral Contraceptive Multipurpose Prevention Technology (cMPT) Development
Population Council's picture
Population Council
11/12/2018 - 10:37
FDA Grants Priority Review to Genentechs Tecentriq in Combination With Abraxane for the Initial Treatment of People With PD-L1-Positive, Metastatic Triple-Negative Breast Cancer
Genentech's picture
Genentech
11/09/2018 - 11:01
Facts Dont Support Republican Claims of Democratic Obstruction on Judicial Nominations
PFAW's picture
PFAW
11/09/2018 - 08:58
In Developing Regions, Greater Investment Is Needed to Help Adolescents Prevent Unintended Pregnancy
Guttmacher Institute's picture
Guttmacher Institute
11/08/2018 - 02:32
Americas Frontline Physicians Oppose the Administrations Decision to Jeopardize Access to Womens Preventive Care
American Academy of Family Physicians's picture
American Academ...
11/07/2018 - 19:25
Day After Resounding Electoral Loss, Trump Introduces Secret Abortion Plan: Rule to Make it Nearly Impossible for Health Insurance Plans in the Affordable Care Act to Cover Abortion
Planned Parenthood's picture
Planned Parenthood
11/06/2018 - 21:00
Americans United Denounces Trump-Pence Administrations Harmful Birth Control Rules; Vows To Continue Fighting Them In Court
Americans United's picture
Americans United
10/31/2018 - 14:26
Phase III Data Showed That Venclexta Plus Gazyva Reduced The Risk Of Disease Worsening Or Death In People With Previously Untreated Chronic Lymphocytic Leukemia With Co-Morbidities
Genentech's picture
Genentech
10/31/2018 - 06:21
ACLU Statement on 40th Anniversary of Pregnancy Discrimination Act
ACLU's picture
ACLU
10/25/2018 - 03:21
Clandestine Abortion in Zimbabwe Contributes to Maternal Medical Complications
Guttmacher Institute's picture
Guttmacher Institute
10/22/2018 - 08:34
Genentechs Tecentriq Plus Chemotherapy (Carboplatin and Abraxane) as an Initial Treatment Helped People With Advanced Non-Squamous Non-Small Cell Lung Cancer Live Significantly Longer Compared to Chemotherapy Alone
Genentech's picture
Genentech
10/19/2018 - 20:22
Genentechs Tecentriq in Combination With Abraxane Improves Outcomes as an Initial Treatment for People With PD-L1-Positive Metastatic Triple-Negative Breast Cancer
Genentech's picture
Genentech
10/19/2018 - 08:20
FDA Approves Label Update for Genentechs Rituxan (Rituximab) in Two Rare Forms of Vasculitis
Genentech's picture
Genentech
10/18/2018 - 15:35
The Population Councils Regine Sitruk-Ware Named By TIME Magazine As One of 50 Most Influential People in Health Care of 2018
Population Council's picture
Population Council
10/18/2018 - 15:08
The Nestorone/Ethinyl Estradiol One-Year Vaginal Contraceptive System
Population Council's picture
Population Council
10/18/2018 - 14:35
Mylan Adds to Women's Healthcare Portfolio With Launch of Generic Depo-Provera Injection
Mylan's picture
Mylan
10/18/2018 - 12:29
Search Our Publications & Projects License Our Products Partner With Us Careers Fellowships
Population Council's picture
Population Council
10/14/2018 - 16:56
Genentechs Kadcyla Reduced the Risk of Disease Recurring in People With HER2-Positive Early Breast Cancer With Residual Disease After Neoadjuvant Treatment
Genentech's picture
Genentech
10/10/2018 - 17:35
Sanofi Presents 8-Year Data on Lemtrada (Alemtuzumab)
Genzyme's picture
Genzyme
10/09/2018 - 16:14
OCREVUS (Ocrelizumab) Data Show Early Initiation of Treatment Reduces Disability Progression over Five Years in Relapsing and Primary Progressive Multiple Sclerosis
Genentech's picture
Genentech
10/07/2018 - 20:17
More Than 30 Data Presentations from Sanofi Genzymes Multiple Sclerosis Franchise to Be Featured at the 34th ECTRIMS Congress
Genzyme's picture
Genzyme
10/07/2018 - 19:06
Libtayo (cemiplimab-rwlc) Data at ESMO 2018 Congress Provide New Insights in Six Tumor Types Under Investigation
Genzyme's picture
Genzyme
10/03/2018 - 18:01
FDA Approves Genentechs Hemlibra (Emicizumab-kxwh) for Hemophilia A Without Factor VIII Inhibitors
Genentech's picture
Genentech
10/01/2018 - 13:43
Genentech to Present Five-Year OCREVUS (Ocrelizumab) Efficacy and Safety Data in Relapsing and Primary Progressive Multiple Sclerosis at ECTRIMS
Genentech's picture
Genentech
10/01/2018 - 01:44
BMC to Lead Education Program for Maternity Providers in Mass. on Contraception Counseling
Boston Medical Center's picture
Boston Medical ...
10/01/2018 - 00:03
Fox Chase Cancer Center Reminds Women to Schedule a Breast Cancer Screening
Fox Chase's picture
Fox Chase
09/28/2018 - 05:43
FDA approves Libtayo (cemiplimab-rwlc) as first and only treatment for advanced cutaneous squamous cell carcinoma
Genzyme's picture
Genzyme
09/26/2018 - 06:06
In clinical trials, new antibody therapy controls HIV for months after treatment
RockefellerUniversity's picture
RockefellerUniv...
09/25/2018 - 02:43
Genentechs TECENTRIQ in Combination With Chemotherapy Helped People Live Significantly Longer as an Initial Treatment for People With Extensive-Stage Small Cell Lung Cancer
Genentech's picture
Genentech
09/24/2018 - 13:47
New Research on Griffithisin and Carageenan to Prevent HIV and STIs Published in Nature Communications
Population Council's picture
Population Council
09/24/2018 - 05:28
HealthPartners Medical Director for Well-being receives Minnesota Medical Associations Presidents Award for work to improve public health
HealthPartners's picture
HealthPartners
09/24/2018 - 02:10
Genentechs TECENTRIQ in Combination With Pemetrexed and Platinum-Based Chemotherapy Reduced the Risk of Disease Worsening or Death in a Type of Previously Untreated Advanced Lung Cancer
Genentech's picture
Genentech
09/19/2018 - 22:47
Most Sexually Active U.S. High School Students Make Decisions That Support Their Sexual Health
Guttmacher Institute's picture
Guttmacher Institute
09/05/2018 - 16:55
Adolescent Contraceptive Needs in Developing Regions: Cost and Impact of Future Growth
Guttmacher Institute's picture
Guttmacher Institute
09/05/2018 - 11:28
Ted L. Anderson, M.D., Ph.D., Announced as ACOG President-Elect
ACOG's picture
ACOG
09/04/2018 - 22:58
Genentech to Present New Data from Its Extensive Lung Cancer Program at the 2018 World Conference on Lung Cancer (WCLC)
Genentech's picture
Genentech
08/31/2018 - 05:31
DFID announces major new funding for Marie Stopes International
Marie Stopes's picture
Marie Stopes
08/30/2018 - 18:28
Improvements in Contraceptive Use Continue to Drive Declines in Pregnancy Among U.S. Adolescents
Guttmacher Institute's picture
Guttmacher Institute
08/29/2018 - 19:21
HHS Issues Grants to Title X Providers It Is Actively Trying to Kick Out of the Title X Program
Planned Parenthood's picture
Planned Parenthood
08/29/2018 - 17:53
New Study Finds Planned Parenthoods Innovative Chat/Text Program Improves Young Peoples Access to Sexual and Reproductive Health Care
Planned Parenthood's picture
Planned Parenthood
08/29/2018 - 10:38
Positive Phase III Results for Genentechs HEMLIBRA (emicizumab-kxwh) for Hemophilia A Without Factor VIII Inhibitors Published in New England Journal of Medicine
Genentech's picture
Genentech
08/10/2018 - 05:26
FDA Approves the First One-Year Contraceptive Fully under a Womans Control
Population Council's picture
Population Council
08/10/2018 - 00:44
FDA approves new vaginal ring for one year of birth control
FDA's picture
FDA
08/09/2018 - 23:49
FDA allows marketing of first direct-to-consumer app for contraceptive use to prevent pregnancy
FDA's picture
FDA
08/07/2018 - 13:31
FDA Approves ORKAMBI (lumacaftor/ivacaftor) as First Medicine to Treat the Underlying Cause of Cystic Fibrosis for Children Ages 2-5 Years with Most Common Form of the Disease
Vertex's picture
Vertex
08/01/2018 - 02:25
NCLs statement on Trump Administrations proposed rule on Title X
National Consumers League's picture
National Consum...
07/31/2018 - 17:29
AMA Opposes Proposed Rule on Title X Family Planning Program
AMA's picture
AMA
07/31/2018 - 15:32
Population Council Announces New License Agreement
Population Council's picture
Population Council
07/24/2018 - 17:00
Over a Hundred People March to Department of Health and Human Services In Opposition of Trumps Gag Rule
Planned Parenthood's picture
Planned Parenthood
07/20/2018 - 17:40
Ipas Mexico study finds sexual violence a principal factor in child pregnancies
Ipas's picture
Ipas
07/20/2018 - 07:03
Statement from FDA Commissioner Scott Gottlieb, M.D., on manufacturer announcement to halt Essure sales in the U.S.; agencys continued commitment to postmarket review of Essure and keeping women informed
FDA's picture
FDA
07/18/2018 - 14:25
Novartis Kisqali now first and only CDK4/6 inhibitor indicated in US as first-line therapy specifically for premenopausal women; and as initial therapy with fulvestrant in postmenopausal women
Novartis's picture
Novartis
07/18/2018 - 06:56
Genentechs TECENTRIQ in Combination With Pemetrexed and Platinum-Based Chemotherapy Reduced the Risk of Disease Worsening or Death in the Initial Treatment of People With Advanced Lung Cancer
Genentech's picture
Genentech